ADMA Biologics, Inc.
ADMA Biologics, Inc. (ADMA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
adma · stock forecast · 10 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$24.00
Consensus
$21.00
+163.5% upside
Low
$18.00
Median: $21 · Last Close: $7.97
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$21.00
163.5% upside
High Target
$24
201.1%
Low Target
$18
125.8%
Current Price
$7.97
as of today
Based on analyst price targets, the ADMA stock price prediction for the next 12 months ranges from $18 to $24. The consensus ADMA price forecast of $21.00 implies 163.5% upside from the current price of $7.97.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.71 | ↓ 3.27% |
1-day model range: $7.64–$7.78. Peak: $7.78 (-3.27%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $11 | +39.5% |
| 2028 | $14 | +69.7% |
| 2029 | $15 | +90.0% |
| 2030 | $16 | +102.5% |
| 2031 | — | +109.8% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ADMA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-07 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-05-07 | Mizuho | Maintains | Outperform→Outperform |
| 2026-04-13 | Mizuho | Maintains | Outperform→Outperform |
| 2026-03-26 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2025-05-08 | Raymond James | Maintains | Strong Buy→Strong Buy |
| 2025-03-04 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2024-11-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-08 | Raymond James | Maintains | Strong Buy→Strong Buy |
| 2024-10-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-09-20 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on ADMA Biologics, Inc. (ADMA) stock. Of the recent 58 rating actions, 3 were upgrades and 4 were downgrades. 10 analysts currently cover ADMA.
Analyst Recommendation Trends
ADMA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$570M
↓ 30.8% YoY
Revenue Next Year
$689M
↑ 20.9% YoY
EPS This Year
$0.84
EPS Next Year
$1.08
↑ 28.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast ADMA EPS of $0.84 for the current fiscal year, based on estimates from 2 analysts. The ADMA revenue forecast is $570M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ADMA stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ADMA price target is $21.00 (+163.5% upside), with an analyst consensus of Buy.
The ADMA short-term stock prediction for tomorrow is $7.71 (-3.27%). The ADMA stock price prediction for 2027 estimates an average of $11. The ADMA stock prediction for 2030 projects a range of $15–$17.
ADMA Biologics, Inc. trades on NASDAQ under the ticker ADMA. The ADMA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 90% of covering analysts.
Frequently asked questions
ADMA forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month ADMA price target is $21.00, with a high forecast of $24.00 and a low of $18.00. The median price target is shown in the chart above when available. This implies +163.5% potential upside from the current price of $7.97.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.